New York, New York (PRWEB) January 31, 2015
The testosterone lawyers (http://www.testosteronelawsuithub.com/testosterone-lawyer/) at Bernstein Liebhard LLP note the publication of a new study that purports to question the association among prescription testosterone therapy and severe cardiovascular problems. The study, which was published in Mayo Clinic Proceedings, consisted of a review of scientific literature going back to 1940. Whilst the authors of the report located “no massive, lengthy-term, placebo-controlled randomized clinical trials in the field of therapy to give definitive conclusions about cardiovascular threat,” they concluded that the balance of the proof shows that low testosterone therapy is secure.*

It should be noted that the authors of the report incorporate members of the Androgen Study Group, which has been criticized for its partnership with the pharmaceutical business. For this study, the authors disclosed ties to a quantity of testosterone therapy producers, such as Abbvie, Auxilium, Eli Lilly and Endo Pharmaceuticals.**

“These findings come just months soon after a panel of FDA advisors suggested that the producers of testosterone therapies undertake massive studies to much better assess their heart dangers, and it contradicts the findings of a number of testosterone research published more than the previous year,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices.*** The Firm is representing guys who allegedly suffered significant cardiovascular issues due to their use of low testosterone therapy, and continues to supply totally free case reviews to these who could have been harmed by prescription testosterone goods.

Testosterone Therapy Litigation
Testosterone therapies have been the subject of concern considering that the U.S. Meals & Drug Administration (FDA) announced on January 31, 2014 that it had launched a evaluation of their safety, after studies indicated the drugs could raise the threat of heart attack, stroke and death in certain males. These studies integrated analysis that was published in November 2013 in the Journal of the American Healthcare Program that suggested an elevated risk of heart attack, stroke and death amongst older men with pre-current heart issues. A second observational study reported that such treatments ware related with a doubling of the heart attack danger amongst younger guys with pre-existing heart issues, and in men more than 65 regardless of their heart health, the FDA stated.

Court records indicate that a lot more than 280 testosterone lawsuits are now pending in a federal multidistrict litigation now underway in U.S. District Court, Northern District of Illinois. All of the claims were filed on behalf males who allegedly skilled heart attacks, strokes, blood clots, and other cardiovascular troubles due to their use of these medications. Amongst other issues, these lawsuits accuse drug makers of failing to adequately warn about the association amongst testosterone replacement therapy and life-threatening heart complications. Plaintiffs additional accuse the businesses of concealing details about these side effects, and claim that misleading advertising and marketing claims about the rewards of testosterone products drove healthier males to take them. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

In September, a panel of FDA advisors recommended that labeling on testosterone medicines be adjusted to make clear their lack of verified effectiveness in treating low libido, fatigue, muscle loss and other symptoms men usually expertise as they age. Panelists also advised that the FDA need makers of testosterone replacement therapies to conduct huge-scale studies of their cardiovascular side effects.***

Males who allegedly suffered serious cardiovascular events due to their use of prescription testosterone therapies may possibly be entitled to compensation for their injury-connected damages. To learn more about filing a testosterone treatment lawsuit, please go to Bernstein Liebhard LLP’s internet site. Free of charge, no-obligation legal consultations can be obtained by calling 800-511-5092.

*mayoclinicproceedings.org/pb/assets/raw/Wellness%20Advance/journals/jmcp/jmcp_ft90_1_2.pdf, Mayo Clinic Proceedings, February 2015
**medpagetoday.com/Endocrinology/GeneralEndocrinology/49789, Med Web page Today, January 30, 2015
*** http://www.nytimes.com/2014/09/18/health/testosterone-drugs-fda.html?_r= ,New York Occasions, September 17, 2014

About Bernstein Liebhard LLP 
Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide considering that 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources necessary to successfully challenge billion dollar pharmaceutical and healthcare device businesses. As a outcome, our attorneys and legal employees have been capable to recover a lot more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the previous 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list each and every year given that it was initial published in 2003.

Bernstein Liebhard LLP 
10 East 40th Street 
New York, New York 10016 
800-511-5092

Lawyer Advertising. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not assure or predict a related outcome with respect to any future matter.

Make contact with Data: 
Felecia L. Stern, Esq. 
Bernstein Liebhard LLP 
info (at) consumerinjurylawyers (dot) com 
http://www.testosteronelawsuithub.com/ 
https://plus.google.com/115936073311125306742?rel=author





Connected Food Therapy Press Releases